Diane Jorkasky Biography and Net Worth

Director of Altimmune

Diane K. Jorkasky, M.D. FACP is a highly regarded pharmaceutical industry executive with a broad background across research and all phases of clinical development in multiple therapeutic areas. In addition to being a member of Altimmune’s Board, Dr. Jorkasky also serves as a Director on the Board of Alzheon, Inc. Prior to her current roles, she was Chief Medical Officer and Head of Development of Complexa Inc., Chief Medical Officer of Endo Pharmaceuticals, and Chief Development and Medical Officer of Aileron Therapeutics, Inc. Her experience also includes executive positions with Pfizer as its Vice President of Global Clinical Research Operations, where she was responsible for all exploratory development, clinical pharmacology and translational medicine. Of her many accomplishments, she led Pfizer’s international Clinical Research Units which received certification by American Accreditation for Human Rights Protection Policies for their clinical research process, the first in industry or academia to achieve such a recognition. Previously, Dr. Jorkasky was Vice President of Clinical Research at SmithKline Beecham, and Chief of Nephrology at Presbyterian-Penn Medical Center in Philadelphia.

What is Diane Jorkasky's net worth?: The estimated net worth of Diane Jorkasky is at least $1.52 thousand as of December 29th, 2025. Dr. Jorkasky owns 527 shares of Altimmune stock worth more than $1,523 as of April 24th. This net worth evaluation does not reflect any other assets that Dr. Jorkasky may own. Learn More about Diane Jorkasky's net worth.
How do I contact Diane Jorkasky?: The corporate mailing address for Dr. Jorkasky and other Altimmune executives is 910 CLOPPER ROAD SUITE 201S, GAITHERSBURG MD, 20878. Altimmune can also be reached via phone at (240) 654-1450 and via email at [email protected]. Learn More on Diane Jorkasky's contact information.
Has Diane Jorkasky been buying or selling shares of Altimmune?: Diane Jorkasky has not been actively trading shares of Altimmune within the last three months. Most recently, on Monday, December 29th, Diane Jorkasky bought 527 shares of Altimmune stock. The stock was acquired at an average cost of $3.80 per share, with a total value of $2,002.60. Following the completion of the transaction, the director now directly owns 527 shares of the company's stock, valued at $2,002.60. Learn More on Diane Jorkasky's trading history.
Who are Altimmune's active insiders?: Altimmune's insider roster includes Jerome Durso (CEO), John Gill (Director), Matthew Harris (Insider), Diane Jorkasky (Director), Wayne Pisano (Director), and Gregory Weaver (CFO). Learn More on Altimmune's active insiders.
Are insiders buying or selling shares of Altimmune?: During the last twelve months, Altimmune insiders bought shares 6 times. They purchased a total of 55,527 shares worth more than $213,777.60. The most recent insider tranaction occured on March, 6th when CFO Gregory L Weaver bought 5,000 shares worth more than $17,700.00. Insiders at Altimmune own 1.6% of the company. Learn More about insider trades at Altimmune.
Information on this page was last updated on 3/6/2026.

Diane Jorkasky Insider Trading History at Altimmune

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/29/2025	Buy	527	$3.80	$2,002.60	527
6/27/2022	Sell	17,610	$11.75	$206,917.50

Diane Jorkasky Buying and Selling Activity at Altimmune

Altimmune Company Overview

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Today's Range

Now: $2.94

$2.93

$3.01

50 Day Range

MA: $3.68

$2.88

$4.57

2 Week Range

Now: $2.94

$2.80

$7.73

Volume

1,791,268 shs

Average Volume

4,425,906 shs

Market Capitalization

$381.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.34